Literature DB >> 7485690

Bubonic leishmaniasis: a common manifestation of Leishmania (Viannia) braziliensis infection in Ceara, Brazil.

A de Q Sousa1, M E Parise, M M Pompeu, J M Coehlo Filho, I A Vasconcelos, J W Lima, E G Oliveira, A W Vasconcelos, J R David, J H Maguire.   

Abstract

Enlarged regional lymph nodes have been reported to accompany the cutaneous lesions of Leishmania (Viannia) braziliensis (= L. braziliensis). A survey in Ceara State, Brazil indicated that 77% of persons (456 of 595) with parasitologically confirmed cutaneous leishmaniasis reported lymphadenopathy in addition to skin lesions. A group of 169 persons with recently diagnosed leishmaniasis and lymph nodes measuring > or = 2 cm in diameter (mean = 3.6 cm, maximum = 10.5 cm) underwent detailed clinical examination. Lymphadenopathy preceded the skin lesions in more than two-thirds of these, on the average by two weeks. Cultures of lymph node aspirates yielded Leishmania more frequently (86%) than cultures of aspirates of skin (53%) or biopsies of skin (74%). Parasites were isolated from the peripheral blood of one patient. Persons with lymphadenopathy gave a history of fever and had enlarged livers or spleens more often than a comparison group of 50 persons with cutaneous lesions but no lymphadenopathy. Persons with lymphadenopathy had more intense leishmanin skin reactions and lymphocyte proliferation following stimulation with specific antigens, whereas persons without lymphadenopathy had a higher frequency of previous infection. Isolates of parasites from both groups were identified as L. braziliensis. These data demonstrate the early spread of L. braziliensis beyond the skin and suggest differences in host immunity between persons with and without lymphadenopathy. Leishmaniasis braziliensis should be considered in cases of unexplained lymphadenopathy in endemic areas.

Entities:  

Mesh:

Year:  1995        PMID: 7485690     DOI: 10.4269/ajtmh.1995.53.380

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  16 in total

1.  Role of Toll-like receptor 9 signaling in experimental Leishmania braziliensis infection.

Authors:  Tiffany Weinkopff; Anita Mariotto; Gregoire Simon; Yazmin Hauyon-La Torre; Floriane Auderset; Steffen Schuster; Haroun Zangger; Nicolas Fasel; Aldina Barral; Fabienne Tacchini-Cottier
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

Review 2.  Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis.

Authors:  Advait S Nagle; Shilpi Khare; Arun Babu Kumar; Frantisek Supek; Andriy Buchynskyy; Casey J N Mathison; Naveen Kumar Chennamaneni; Nagendar Pendem; Frederick S Buckner; Michael H Gelb; Valentina Molteni
Journal:  Chem Rev       Date:  2014-11-03       Impact factor: 60.622

3.  Press imprint smear: a rapid, simple, and cheap method for the diagnosis of cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis.

Authors:  Anastácio Q Sousa; Margarida M L Pompeu; Mércia S Frutuoso; José W O Lima; Juliana M B M Tinel; Richard D Pearson
Journal:  Am J Trop Med Hyg       Date:  2014-08-11       Impact factor: 2.345

4.  Distinct Leishmania braziliensis isolates induce different paces of chemokine expression patterns.

Authors:  Maria Jania Teixeira; Juliana Dumet Fernandes; Clarissa Romero Teixeira; Bruno Bezerril Andrade; Margarida Lima Pompeu; João Santana da Silva; Cláudia Ida Brodskyn; Manoel Barral-Netto; Aldina Barral
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

5.  Is Leishmania (Viannia) braziliensis preferentially restricted to the cutaneous lesions of naturally infected dogs?

Authors:  Maria de Fátima Madeira; Armando de O Schubach; Tânia M P Schubach; Cathia M B Serra; Sandro A Pereira; Fabiano B Figueiredo; Eliame Mouta Confort; Leonardo P Quintella; Mauro C A Marzochi
Journal:  Parasitol Res       Date:  2005-06-29       Impact factor: 2.289

6.  Characterization of the T-cell receptor Vbeta repertoire in the human immune response against Leishmania parasites.

Authors:  Jorge Clarêncio; Camila I de Oliveira; Glória Bomfim; Margarida M Pompeu; Maria Jania Teixeira; Theolis C Barbosa; Sebastião Souza-Neto; Edgar M Carvalho; Cláudia Brodskyn; Aldina Barral; Manoel Barral-Netto
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

7.  The Elderly Respond to Antimony Therapy for Cutaneous Leishmaniasis Similarly to Young Patients but Have Severe Adverse Reactions.

Authors:  Alexsandro Souza do Lago; Maurício Nascimento; Augusto M Carvalho; Neuza Lago; Juliana Silva; José Roberto Queiroz; Lucas P Carvalho; Albert Schriefer; Mary Wilson; Paulo Machado; Edgar M Carvalho
Journal:  Am J Trop Med Hyg       Date:  2018-03-22       Impact factor: 2.345

8.  Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice.

Authors:  F Janaina Soares Rocha; Ulrike Schleicher; Jochen Mattner; Gottfried Alber; Christian Bogdan
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

9.  Fluconazole effectiveness against Leishmania (Viannia) braziliensis: is the evidence enough?

Authors:  Jaime R Torres; José A Suárez
Journal:  Clin Infect Dis       Date:  2012-04-20       Impact factor: 9.079

Review 10.  Drought, smallpox, and emergence of Leishmania braziliensis in northeastern Brazil.

Authors:  Anastácio Q Sousa; Richard Pearson
Journal:  Emerg Infect Dis       Date:  2009-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.